Febuxostat Clydesdale Pharma

Febuxostat Clydesdale Pharma is a medication used to manage uric acid levels in the body. It is commonly prescribed for conditions related to high uric acid, such as gout. This oral medication is manufactured by Clydesdale Pharma Limited.

Febuxostat Clydesdale Pharma is primarily used to lower uric acid levels in individuals with gout or certain kidney problems. By reducing uric acid, it helps prevent gout attacks and the formation of uric acid stones in the kidneys. It is often prescribed for long-term management rather than immediate relief.

Common effects of Febuxostat Clydesdale Pharma may include nausea, diarrhea, and rash. Some individuals might experience liver function abnormalities or mild headaches. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Febuxostat Clydesdale Pharma should be used with caution in individuals with liver or kidney disease. It is important to follow the prescribed dosage and not to exceed it without medical advice. Regular monitoring of liver function may be recommended during treatment.

Febuxostat Clydesdale Pharma may interact with certain medications, including azathioprine, mercaptopurine, and theophylline. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.